Access to medicines as a human right implications for pharmaceutical industry responsibility
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Toronto
University of Toronto Press
[2012]
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042740417 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150806s2012 xx o|||| 00||| eng d | ||
| 020 | |a 9781442661127 |c electronic bk. |9 978-1-4426-6112-7 | ||
| 020 | |a 1442661127 |c electronic bk. |9 1-4426-6112-7 | ||
| 020 | |a 9781442643970 |9 978-1-4426-4397-0 | ||
| 020 | |a 1442643978 |9 1-4426-4397-8 | ||
| 035 | |a (OCoLC)868069010 | ||
| 035 | |a (DE-599)BVBBV042740417 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 174.2/951 |2 23 | |
| 245 | 1 | 0 | |a Access to medicines as a human right |b implications for pharmaceutical industry responsibility |c edited by Lisa Forman and Jillian Clare Kohler |
| 264 | 1 | |a Toronto |b University of Toronto Press |c [2012] | |
| 300 | |a 1 Online-Ressource (vi, 214 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Introduction - access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? - Lisa Forman and Jillian Clare Kohler -- - Human rights responsibilities of pharmaceutical companies in relation to access to medicines - Rajat Khosla and Paul Hunt -- - Improving access to essential medicines : international law and normative change - Asher Alkoby -- - Corporate social responsibility and the right to essential medicines - Patricia Illingworth -- - Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility - Matthew Lee and Jillian Clare Kohler -- - Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? - Joel Lexchin -- - Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform - Richard Eilliott -- - Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa - Judith King and Stephanie Nixon -- - Annex - human rights guidelines for pharmaceutical companies in relation to access to medicines | ||
| 500 | |a "According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health? | ||
| 500 | |a This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher | ||
| 650 | 4 | |a Industrie pharmaceutique / Aspect moral | |
| 650 | 4 | |a Pharmaciens / Déontologie | |
| 650 | 4 | |a Droits de l'homme (Droit international) / Aspect sanitaire | |
| 650 | 4 | |a Entreprises / Responsabilité sociale | |
| 650 | 4 | |a Drug Industry / ethics | |
| 650 | 4 | |a Health Services Accessibility / ethics | |
| 650 | 4 | |a Human Rights | |
| 650 | 4 | |a Social Responsibility | |
| 650 | 7 | |a Human rights / Health aspects |2 fast | |
| 650 | 7 | |a Pharmaceutical ethics |2 fast | |
| 650 | 7 | |a Pharmaceutical industry / Moral and ethical aspects |2 fast | |
| 650 | 7 | |a Social responsibility of business |2 fast | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Business Ethics |2 bisacsh | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Menschenrecht | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Pharmaceutical industry |x Moral and ethical aspects | |
| 650 | 4 | |a Pharmaceutical ethics | |
| 650 | 4 | |a Human rights |x Health aspects | |
| 650 | 4 | |a Social responsibility of business | |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Soziale Verantwortung |0 (DE-588)4055737-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ethik |0 (DE-588)4015602-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Verantwortungsethik |0 (DE-588)4236475-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |8 2\p |0 (DE-588)4522595-3 |a Fallstudiensammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Soziale Verantwortung |0 (DE-588)4055737-6 |D s |
| 689 | 0 | 2 | |a Ethik |0 (DE-588)4015602-3 |D s |
| 689 | 0 | |8 3\p |5 DE-604 | |
| 689 | 1 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 1 | |a Verantwortungsethik |0 (DE-588)4236475-9 |D s |
| 689 | 1 | |8 4\p |5 DE-604 | |
| 700 | 1 | |a Forman, Lisa |e Sonstige |4 oth | |
| 700 | 1 | |a Kohler, Jillian Clare |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=682866 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBU | ||
| 912 | |a ZDB-4-NLEBK | ||
| 940 | 1 | |q FLA_PDA_EBU | |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028171289 | |
Datensatz im Suchindex
| _version_ | 1819294814557962240 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042740417 |
| collection | ZDB-4-EBU ZDB-4-NLEBK |
| ctrlnum | (OCoLC)868069010 (DE-599)BVBBV042740417 |
| dewey-full | 174.2/951 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174.2/951 |
| dewey-search | 174.2/951 |
| dewey-sort | 3174.2 3951 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05792nam a2200841zc 4500</leader><controlfield tag="001">BV042740417</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150806s2012 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442661127</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-4426-6112-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1442661127</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-4426-6112-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442643970</subfield><subfield code="9">978-1-4426-4397-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1442643978</subfield><subfield code="9">1-4426-4397-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)868069010</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042740417</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">174.2/951</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Access to medicines as a human right</subfield><subfield code="b">implications for pharmaceutical industry responsibility</subfield><subfield code="c">edited by Lisa Forman and Jillian Clare Kohler</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Toronto</subfield><subfield code="b">University of Toronto Press</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (vi, 214 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction - access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? - Lisa Forman and Jillian Clare Kohler -- - Human rights responsibilities of pharmaceutical companies in relation to access to medicines - Rajat Khosla and Paul Hunt -- - Improving access to essential medicines : international law and normative change - Asher Alkoby -- - Corporate social responsibility and the right to essential medicines - Patricia Illingworth -- - Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility - Matthew Lee and Jillian Clare Kohler -- - Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? - Joel Lexchin -- - Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform - Richard Eilliott -- - Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa - Judith King and Stephanie Nixon -- - Annex - human rights guidelines for pharmaceutical companies in relation to access to medicines</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health?</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique / Aspect moral</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaciens / Déontologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Droits de l'homme (Droit international) / Aspect sanitaire</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entreprises / Responsabilité sociale</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry / ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Services Accessibility / ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Rights</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social Responsibility</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human rights / Health aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical ethics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry / Moral and ethical aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social responsibility of business</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Business Ethics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Menschenrecht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human rights</subfield><subfield code="x">Health aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social responsibility of business</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Soziale Verantwortung</subfield><subfield code="0">(DE-588)4055737-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Verantwortungsethik</subfield><subfield code="0">(DE-588)4236475-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Soziale Verantwortung</subfield><subfield code="0">(DE-588)4055737-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Verantwortungsethik</subfield><subfield code="0">(DE-588)4236475-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forman, Lisa</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohler, Jillian Clare</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=682866</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_EBU</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028171289</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)4522595-3 Fallstudiensammlung gnd-content |
| genre_facet | Aufsatzsammlung Fallstudiensammlung |
| id | DE-604.BV042740417 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-24T04:32:18Z |
| institution | BVB |
| isbn | 9781442661127 1442661127 9781442643970 1442643978 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028171289 |
| oclc_num | 868069010 |
| open_access_boolean | |
| physical | 1 Online-Ressource (vi, 214 pages) |
| psigel | ZDB-4-EBU ZDB-4-NLEBK FLA_PDA_EBU |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | University of Toronto Press |
| record_format | marc |
| spelling | Access to medicines as a human right implications for pharmaceutical industry responsibility edited by Lisa Forman and Jillian Clare Kohler Toronto University of Toronto Press [2012] 1 Online-Ressource (vi, 214 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Introduction - access to medicines as a human right : what does it mean for pharmaceutical industry responsibilities? - Lisa Forman and Jillian Clare Kohler -- - Human rights responsibilities of pharmaceutical companies in relation to access to medicines - Rajat Khosla and Paul Hunt -- - Improving access to essential medicines : international law and normative change - Asher Alkoby -- - Corporate social responsibility and the right to essential medicines - Patricia Illingworth -- - Benchmarking and transparency : incentives for the pharmaceutical industry's corporate social responsibility - Matthew Lee and Jillian Clare Kohler -- - Social responsibility and marketing of drugs in developing countries : a goal or an oxymoron? - Joel Lexchin -- - Managing the market for medicines access : realizing the right to health by facilitating compulsory licensing of pharmaceuticals : a case study of legislation and the need for reform - Richard Eilliott -- - Ubuntu, AIDS, and the King II report : reflections on corporate social responsibility in South Africa - Judith King and Stephanie Nixon -- - Annex - human rights guidelines for pharmaceutical companies in relation to access to medicines "According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health? This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue"--Provided by publisher Industrie pharmaceutique / Aspect moral Pharmaciens / Déontologie Droits de l'homme (Droit international) / Aspect sanitaire Entreprises / Responsabilité sociale Drug Industry / ethics Health Services Accessibility / ethics Human Rights Social Responsibility Human rights / Health aspects fast Pharmaceutical ethics fast Pharmaceutical industry / Moral and ethical aspects fast Social responsibility of business fast BUSINESS & ECONOMICS / Business Ethics bisacsh Ethik Menschenrecht Wirtschaft Pharmaceutical industry Moral and ethical aspects Pharmaceutical ethics Human rights Health aspects Social responsibility of business Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Soziale Verantwortung (DE-588)4055737-6 gnd rswk-swf Ethik (DE-588)4015602-3 gnd rswk-swf Verantwortungsethik (DE-588)4236475-9 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)4522595-3 Fallstudiensammlung gnd-content Pharmazeutische Industrie (DE-588)4045696-1 s Soziale Verantwortung (DE-588)4055737-6 s Ethik (DE-588)4015602-3 s 3\p DE-604 Verantwortungsethik (DE-588)4236475-9 s 4\p DE-604 Forman, Lisa Sonstige oth Kohler, Jillian Clare Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=682866 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Access to medicines as a human right implications for pharmaceutical industry responsibility Industrie pharmaceutique / Aspect moral Pharmaciens / Déontologie Droits de l'homme (Droit international) / Aspect sanitaire Entreprises / Responsabilité sociale Drug Industry / ethics Health Services Accessibility / ethics Human Rights Social Responsibility Human rights / Health aspects fast Pharmaceutical ethics fast Pharmaceutical industry / Moral and ethical aspects fast Social responsibility of business fast BUSINESS & ECONOMICS / Business Ethics bisacsh Ethik Menschenrecht Wirtschaft Pharmaceutical industry Moral and ethical aspects Pharmaceutical ethics Human rights Health aspects Social responsibility of business Pharmazeutische Industrie (DE-588)4045696-1 gnd Soziale Verantwortung (DE-588)4055737-6 gnd Ethik (DE-588)4015602-3 gnd Verantwortungsethik (DE-588)4236475-9 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4055737-6 (DE-588)4015602-3 (DE-588)4236475-9 (DE-588)4143413-4 (DE-588)4522595-3 |
| title | Access to medicines as a human right implications for pharmaceutical industry responsibility |
| title_auth | Access to medicines as a human right implications for pharmaceutical industry responsibility |
| title_exact_search | Access to medicines as a human right implications for pharmaceutical industry responsibility |
| title_full | Access to medicines as a human right implications for pharmaceutical industry responsibility edited by Lisa Forman and Jillian Clare Kohler |
| title_fullStr | Access to medicines as a human right implications for pharmaceutical industry responsibility edited by Lisa Forman and Jillian Clare Kohler |
| title_full_unstemmed | Access to medicines as a human right implications for pharmaceutical industry responsibility edited by Lisa Forman and Jillian Clare Kohler |
| title_short | Access to medicines as a human right |
| title_sort | access to medicines as a human right implications for pharmaceutical industry responsibility |
| title_sub | implications for pharmaceutical industry responsibility |
| topic | Industrie pharmaceutique / Aspect moral Pharmaciens / Déontologie Droits de l'homme (Droit international) / Aspect sanitaire Entreprises / Responsabilité sociale Drug Industry / ethics Health Services Accessibility / ethics Human Rights Social Responsibility Human rights / Health aspects fast Pharmaceutical ethics fast Pharmaceutical industry / Moral and ethical aspects fast Social responsibility of business fast BUSINESS & ECONOMICS / Business Ethics bisacsh Ethik Menschenrecht Wirtschaft Pharmaceutical industry Moral and ethical aspects Pharmaceutical ethics Human rights Health aspects Social responsibility of business Pharmazeutische Industrie (DE-588)4045696-1 gnd Soziale Verantwortung (DE-588)4055737-6 gnd Ethik (DE-588)4015602-3 gnd Verantwortungsethik (DE-588)4236475-9 gnd |
| topic_facet | Industrie pharmaceutique / Aspect moral Pharmaciens / Déontologie Droits de l'homme (Droit international) / Aspect sanitaire Entreprises / Responsabilité sociale Drug Industry / ethics Health Services Accessibility / ethics Human Rights Social Responsibility Human rights / Health aspects Pharmaceutical ethics Pharmaceutical industry / Moral and ethical aspects Social responsibility of business BUSINESS & ECONOMICS / Business Ethics Ethik Menschenrecht Wirtschaft Pharmaceutical industry Moral and ethical aspects Human rights Health aspects Pharmazeutische Industrie Soziale Verantwortung Verantwortungsethik Aufsatzsammlung Fallstudiensammlung |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=682866 |
| work_keys_str_mv | AT formanlisa accesstomedicinesasahumanrightimplicationsforpharmaceuticalindustryresponsibility AT kohlerjillianclare accesstomedicinesasahumanrightimplicationsforpharmaceuticalindustryresponsibility |